MetLife Investment Management’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154K Sell
44,208
-13,362
-23% -$50.9K ﹤0.01% 2344
2025
Q4
$200K Buy
57,570
+14,573
+34% +$64.8K ﹤0.01% 2273
2025
Q3
$238K Buy
42,997
+3,983
+10% +$16.2K ﹤0.01% 2220
2025
Q2
$96.4K Buy
+39,014
New +$60.1K ﹤0.01% 2560
2025
Q1
Sell
-25,031
Closed -$73.1K 2818
2024
Q4
$73.1K Sell
25,031
-9,097
-27% -$31.9K ﹤0.01% 2702
2024
Q3
$132K Hold
34,128
﹤0.01% 2508
2024
Q2
$175K Buy
34,128
+12,866
+61% +$78K ﹤0.01% 2332
2024
Q1
$149K Hold
21,262
﹤0.01% 2350
2023
Q4
$188K Hold
21,262
﹤0.01% 2273
2023
Q3
$203K Hold
21,262
﹤0.01% 2199
2023
Q2
$311K Buy
21,262
+15,171
+249% +$212K ﹤0.01% 1992
2023
Q1
$74.9K Hold
6,091
﹤0.01% 2656
2022
Q4
$113K Buy
+6,091
New +$110K ﹤0.01% 2543

Other funds holding PRME